ARLINGTON, Va.--(BUSINESS WIRE)--CERTIFY Health is excited to announce that VHC Health (VHC), a community-based health system providing medical services to...
PRINCETON, NJ / ACCESSWIRE / June 2, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined...
First commercial launch of the Company's nutraceutical products in the U.S. follows successful launches on Amazon in other key marketsCHICAGO,...
60-patient enrollment target met plus 12% over-enrollment; top-line Phase 2a results expected to be presented during the European Sleep Research...
TORONTO, ON / ACCESSWIRE / June 2, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health...
ALPHARETTA, GA / ACCESSWIRE / June 2, 2022 / Rushnet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that...
Attends Christmas Cosmetic Trade Show Securing 10 New Stockists, Enters Distribution Partnership DiscussionsLONDON, UK / ACCESSWIRE / June 2, 2022...
ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
CAMBRIDGE, MA / ACCESSWIRE / June 2, 2022 / Moderna, Inc.(NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Earlier this year, a national pharmacy benefit manager (PBM) moved a large percentage of its patients from not covered to...
Jamie Donadio Jamie Donadio, CFO, Renibus Therapeutics Dr. Bhupinder Singh Dr. Bhupinder Singh, CMO, Renibus TherapeuticsJamie Donadio appointed Chief Financial...
Transaction expected to significantly advance commercial readiness of NanoSynex’s innovative diagnostics technology platform focused on the $30+ Billion global infectious...
DALLAS, June 02, 2022 (GLOBE NEWSWIRE) -- Gradalis, a late-stage stage biotechnology company developing immunotherapies for multiple cancer indications, announced...
Hillstream BioPharma CEO Issues June 2022 Corporate Update Hillstream BioPharma CEO Issues June 2022 Corporate UpdateRecent milestones include FDA Orphan...
NEW HAVEN, Conn., June 02, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class...
CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused...